3620 results for «2430»
3620 results
Pharmacotherapy coronary interventions: new insights
22 May 2025 – From EuroPCR 2025
Stay abreast of new insights in pharmacotherapy for coronary interventions with a focus on optimizing patient outcomes. Topics include ticagrelor monotherapy in chronic coronary syndrome post-PCI, analysis of multiple events in high bleeding risk patients from the MASTER DAPT trial, effects of beta-blocker interruption in MI...
What an interventional cardiologist should know about anti-thrombotics
22 May 2025 – From EuroPCR 2025
This session provides comprehensive knowledge on anti-thrombotic management for interventional cardiologists, emphasizing effective inhibition during acute STEMI, latest evidence implementation for high bleeding risk patients, and customization of dual antiplatelet therapy in patients with high thrombotic and low bleeding risks through clinical cases and evidence-based recommendations.
Optimal use of cardiac imaging to plan and guide transcatheter LAA closure
22 May 2025 – From EuroPCR 2025
Optimize left atrial appendage (LAA) closure outcomes through expert use of cardiac imaging. This session details the role of various imaging modalities in pre-procedural planning, intraprocedural guidance, and post-procedural assessment. Gain practical insights on transesophageal echocardiography, computed tomography, intracardiac echocardiography, and their integration to enhance procedural...
Procedural planning and risk stratification in multivessel PCI
22 May 2025 – From EuroPCR 2025
This session focuses on procedural planning and risk stratification in multivessel PCI, presenting data from the TALENT and FIRE trials, prognostic value of post-PCI physiological assessments, and an innovative study comparing large language models in managing complex interventional cardiology cases.
TAVI in bicuspid aortic valve disease
22 May 2025 – From EuroPCR 2025
Explore the unique challenges of TAVI in bicuspid aortic valve disease with a focus on long-term outcomes, residual gradients, prosthesis-patient mismatch, and anatomical subtype comparisons. This session draws on international registry data to inform clinical decision-making and optimize procedural strategies in this complex patient population.
TAVI in difficult scenarios: bicuspid anatomy and pure aortic regurgitation
22 May 2025 – From EuroPCR 2025
Address challenging TAVI scenarios involving bicuspid anatomy and pure aortic regurgitation with insights from international experiences. This session compares treatment options in China and Germany, explores anatomical and disease differences, and reviews various TAVI devices through detailed case presentations and expert commentary.
Outcome prediction using artificial intelligence and meta-analysis
22 May 2025 – From EuroPCR 2025
This session presents outcome prediction advancements through artificial intelligence and meta-analysis in cardiology. Topics include AI-guided aortic stenosis risk stratification, predictors of periprocedural stroke after TAVI, patient-specific computer simulations for bicuspid TAVI, and enhancements in large language model accuracy using Heart Team simulation.
Imaging makes it clear!
22 May 2025 – From EuroPCR 2025
Explore the critical role of intravascular imaging in interventional cardiology through real-world cases. This session highlights the value of intravascular ultrasound (IVUS) in avoiding unnecessary stenting in STEMI patients, the application of optical coherence tomography (OCT) in complex scenarios, and the management of calcified lesions with...
Antiplatelet strategies for patients undergoing PCI
22 May 2025 – From EuroPCR 2025
Delve into this comprehensive session focusing on antiplatelet strategies for patients undergoing PCI. Explore evidence and clinical insights on ticagrelor monotherapy post-AMI stenting, shortened dual antiplatelet therapy (DAPT) durations, the role of CYP2C19 genotyping in stent thrombosis risk, the effectiveness of dual antithrombotic therapy in atrial...
Radiation protection: the good and the bad
22 May 2025 – From EuroPCR 2025
This session provides essential guidance on radiation protection in the cath lab. Learn practical steps to minimize radiation exposure for yourself and your team, manage the ergonomic challenges of protective gear, and develop skills to foster a culture of radiation safety within your workplace. Understand the...
Patients with degenerated aortic bioprothesis - Every case is different
22 May 2025 – From EuroPCR 2025
Delve into the nuanced management of patients with degenerated aortic bioprostheses, emphasizing that no two cases are alike. This session provides expert insights into selecting optimal valve-in-valve TAVI approaches tailored to individual anatomy and clinical context. Learn practical strategies to overcome complex challenges such as coronary...
New frontier in renal denervation: data, devices and developments
22 May 2025 – From EuroPCR 2025
Advance your understanding of renal denervation with the latest data, innovative devices, and emerging developments. This session reviews the 12-month results of the REDUCED 1 trial evaluating the TIVUS system, explores safety and efficacy of novel renal stimulation techniques, and presents outcomes from registries including patients...
Catheter-directed therapy for intermediate-high-risk and high-risk pulmonary embolism; where do we stand?
22 May 2025 – From EuroPCR 2025
Explore the evolving landscape of catheter-directed therapy for intermediate-high and high-risk pulmonary embolism. This session covers patient selection criteria, clinical signs indicating the need for intervention, management of potential complications, and ongoing studies shaping future treatments. Case-based discussions illustrate practical applications and key learnings.
Advancing knowledge and innovations in peripheral interventions
22 May 2025 – From EuroPCR 2025
Expand your expertise in peripheral interventions with a focus on recent innovations and clinical insights. This session covers pre-clinical results of a novel Hybrid Drug-Eluting Stent for below-the-knee arteries, the prognostic impact of proteinuria in LEAD patients with chronic kidney disease, beta-blocker therapy effects post-frozen elephant...
Challenges and risks of percutaneous treatment of calcified lesions
22 May 2025 – From EuroPCR 2025
Learn how to effectively manage calcified coronary lesions and their associated risks in this focused session. Understand the critical role of plaque modification and intravascular imaging, and gain insights into addressing stent thrombosis following interventions on calcified lesions through detailed case analyses.
LAA closure in challenging scenarios
22 May 2025 – From EuroPCR 2025
This session addresses the complexities of left atrial appendage (LAA) closure in challenging anatomical and clinical scenarios. Learn from compelling cases including management of incomplete surgical LAA ligation, closure of large and complex peridevice leaks, and navigating difficult anatomy in elderly patients. Emphasizing innovative techniques and...
DCB in STEMI : why, when and how ?
22 May 2025 – From EuroPCR 2025
Explore the evolving role of drug-coated balloons (DCB) in the management of STEMI patients. This session covers practical approaches including primary PCI with DEB, unconventional solutions in urgent scenarios, and personalized treatment strategies especially in very young patients. Learn how DCB technology intersects with complex lesion...
Contemporary outcomes of PCI patients
22 May 2025 – From EuroPCR 2025
Examine contemporary outcomes in PCI patients through a collection of studies addressing angiographic complication incidences, safety of same-day discharge post-complex PCI, age-related outcome impacts in TAVI patients, and comparative long-term antiplatelet strategies. The session also explores timing effects in routine versus off-hours PCI.
Tricuspid hotline: new devices
22 May 2025 – From EuroPCR 2025
Discover cutting-edge developments in transcatheter tricuspid valve replacement with new device technologies. Review first-in-human trials, early outcomes from multicenter studies, and innovative designs that promise to advance tricuspid regurgitation treatment.
Right heart catheterisation and CT scan for the assessment of A-V valve treated percutaneously
21 May 2025 – From EuroPCR 2025
This session evaluates right heart catheterisation and cardiac CT imaging in the assessment of percutaneously treated atrioventricular valves. Explore clinical outcomes, invasive physiology characterization, annular remodeling, and pulmonary hypertension impact on mitral and tricuspid valve interventions.
